Experimental validation demonstrated that depletion of GRHL2, TP63, and PAX5 effectively reduced tumor cell growth and survival in their dependent cells.<h4>Conclusions</h4>Our approach provides a systematic method to identify precision oncology targets based on expression-driven dependency patterns. The gene discussed is PAX5; the disease is neoplasm.